Humanization of mouse monoclonal antibodies or alpaca nanobody by genetic engineering can increase their similarity to antibodies naturally produced in humans, greatly enhancing their in vivo ...

Due to the ease of nanobody engineering, they can be employed in three nanobody-based therapeutic platforms: platform A, receptor antagonists to interfere with or block the activation of a certain ...

Humanization of mouse monoclonal antibodies by genetic engineering can improve the in-vivo tolerability by increasing their resemblance to antibodies naturally generated in humans. Sino Biological ...